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Abstract
Background: Ankrd2 is a stress responsive protein mainly expressed in muscle cells. Upon 
the application of oxidative stress, Ankrd2 translocates into the nucleus where it regulates the 
activity of genes involved in cellular response to stress. Emery-Dreifuss Muscular Dystrophy 2 
(EDMD2) is a muscular disorder caused by mutations of the gene encoding lamin A, LMNA. As 
well as many phenotypic abnormalities, EDMD2 muscle cells also feature a permanent basal 
stress state, the underlying molecular mechanisms of which are currently unclear. Methods: 
Experiments were performed in EDMD2-lamin A overexpressing cell lines and EDMD2-affected 
human myotubes. Oxidative stress was produced by H
2
O
2
 treatment. Co-immunoprecipitation, 
FHOOXODUVXEIUDFWLRQDWLRQDQGLPPXQRÁXRUHVFHQFHDQDO\VLVZHUHXVHGWRYDOLGDWHWKHUHODWLRQ
between Ankrd2 and forms of lamin A; cellular sensibility to stress was monitored by the 
analysis of Reactive Oxygen Species (ROS) release and cell viability. Results: Our data 
demonstrate that oxidative stress induces the formation of a complex between Ankrd2 and 
lamin A. However, EDMD2-lamin A mutants were able to bind and mislocalize Ankrd2 in the 
nucleus even under basal conditions. Nonetheless, cells co-expressing Ankrd2 and EDMD2-
lamin A mutants were more sensitive to oxidative stress than the Ankrd2-wild type lamin A 
counterpart. Conclusions:)RUWKHÀUVWWLPHZHSUHVHQWHYLGHQFHWKDWLQPXVFOHÀEHUVIURP
patients affected by EDMD2, Ankrd2 has an unusual nuclear localization. By introducing a 
plausible mechanism ruling this accumulation, our data hint at a novel function of Ankrd2 in 
the pathogenesis of EDMD2-affected cells.
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Introduction
Ankrd2, Ankyrin repeat protein 2, is a mechanosensing protein, belonging to the MARP 
(Muscle Ankyrin Repeat Protein) family and is mainly expressed in skeletal muscle [1-3]. ʹ ǡǦϐ 
factor, that ensures Ankrd2 expression to be low in cycling myoblasts, however its expression 
increases upon muscle differentiation [4]. In cycling myoblasts, Ankrd2 is sharply nuclear, 
whereas in forming myotubes it has a typical cytonuclear ȏͷȐǤϐ
its subcellular localization and expression is due to the different roles covered by Ankrd2 
during myogenesis: an earlier nuclear function, and a late sarcomeric one [5]. In the nucleus, 
Ankrd2 binds to multiple transcription factors, such as YB1, ID3, PAX6, LHX2 and MECP2 
[6-8], as well as p53, and PML [6]. In the cytoplasm, Ankrd2 interacts with proteins involved 
in cell signaling, such as Akt2 [9], and PLCJ[7], but also with sarcomeric proteins, such as 
telethonin [6], titin [10] and ZASP6 [11]. 
Ankrd2 shuttling in the nucleus may also be regulated by several types of stress. Oxidative 
stress [9], as well as chronic immobilization [12], exercise [13], or mechanical forces [10] 
promote the overexpression of Ankrd2 and its concomitant nuclear translocation. In these 
conditions, by down-regulating MyoD, Myogenin and their target Myh3 [5], nuclear Ankrd2    ϐǡ     
stress. The tight relation between its role of stress sensor and coordinator of differentiation, ϐʹǲǳǤ
Lamin A, its precursor prelamin A, and lamin C are splicing products encoded by the 
LMNA gene [14]. In the nucleus, along with B-type lamins, they give rise to the nuclear lamina, 
an elastic network linked to the inner nuclear membrane. By interacting with structural and 
enzymatic molecules, lamin A/C are able to comply with several functions, including nuclear 
and DNA protection against mechanical stress, shuttling of proteins from the cytoplasm to ǡϐǡ
cycle and/or differentiation [15-18]. In muscle cells, by interacting with the LINC complex 
proteins, lamin A/C is also connected to sarcomeric proteins [19, 20]. 
As lamin A/C is so deeply involved in many pleiotropic functions, mutations in the 
LMNA gene often result in their alteration, with deleterious consequences for cells and tissue 
physiology. The disorders due to LMNA      ǲǳǡ  Ǧϐǡ   ǡ  ǡ 
systemic, as progeroid syndromes [14]. 
LMNA-related muscle laminopathies cover a wide number of pathologies, the most 
known of which is Emery-Dreifuss Muscular Dystrophy 2 (EDMD2) [21, 22]. EDMD2 is 
characterized by early contractures, progressive muscle atrophy and weakness, with cardiac 
defects that cause conduction system disorders and dilated cardiomyopathy and may lead 
to sudden death; in particular, several pathogenetic variants of LMNA, mapping on diverse    ǡ   ϐ     ʹ ȏʹʹǦʹͶȐǤ        ϐǡ LMNA result in a ϐ ǡ   ȏʹͷȐǤ ϐ
also suggest an impairment of signaling mechanisms affecting the regulation of muscle-ϐȏʹͳȐǤǡ
to altered levels of reactive oxygen species and a higher susceptibility to oxidative stress 
[26]. Multiple evidence points to mutations on lamin A/C, and on the resulting dysfunctional 
lamina, to be indeed responsible for an altered redox homeostasis [27]. Beside lamin A/C, 
also prelamin A, the precursor of lamin A longer for 15 amino acids, plays a fundamental 
role in muscle cells. We have in the past demonstrated that in normal conditions, prelamin 
A is accumulated during muscle cell differentiation [28]. Moreover, by interacting with LINC 
complex, farnesylated-prelamin A, one intermediate of lamin A processing [29], contributes ϐǡ
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pathogenic mechanisms of dystrophic muscle cells accumulating a mutated form of prelamin 
A [30].
In this study, we present evidence of the formation of a complex made of Ankrd2, mature 
lamin A and farnesylated prelamin A, suggesting an involvement of lamin A and prelamin 
A in Ankrd2 nuclear translocation observed during the arrival of certain stimuli, such as 
myogenic stimulation or stress conditions. In an attempt to assess whether mutations of 
LMNA causative of EDMD2 might affect Ankrd2 binding to lamin A, we unexpectedly found 
that pathological EDMD2-lamin A mutations positively affect this binding and promote ʹǡǤǡϐʹʹϐ
a relevant role in the pathogenesis of this condition by increasing cellular sensibility to 
oxidative stress.
Materials and Methods
Cultures, transfection and treatments
Human muscle cultures were obtained as previously described [31] from consenting patients ǡϐ Ǥʹ
affected donor in which a novel LMNA mutation (c.1517A>C) was diagnosed (Cenni et al, manuscript in 
preparation). All the local and EU ethical issues were respected. 
Human embryonic kidney (HEK) 293T cells and C2C12 myoblasts were cultured in DMEM-High Glucose 
(Life-Technologies, Netherlands) supplemented with 10% of heat-inactivated Fetal Calf Serum (EuroClone, 
Leeds, U.K.). C2C12
 
were induced to differentiate in DMEM-HG plus 2% Horse Serum (Euroclone). HEK 293T 
were transfected with Fugene6 (Promega Madison, USA), and C2C12 with Lipofectamine-3000 (Invitrogen, 
Waltham, USA). 
Oxidative stress was induced by H
2
O
2
ȋǦǡǤȌϐͶͷͲPM 
for HEK 293T and C2C12 cells for the indicated times. Lower H
2
O
2 
concentration (f.c. 100µM) was used for 
primary muscle cultures, to exclude sublethal effects. 
Plasmids
For Ankrd2: Flag tagged human Ankrd2 was previously described in [9]. GFP-tagged human Ankrd2 
cDNA, encoding for the S-Ankrd2 isoform of 333 aminoacids, described by Jasnic-Savovic et al. [3], was 
cloned into the pCDNA 3.1 eukaryotic expression vector (Invitrogen). For Flag-lamin A: Flag-lamin A WT 
[32], Flag-lamin A WT cDNA was used as a template to generate mutants C661M, L647R, R401C, R527P and 
H506P by means of QuikChange strat egy (Agilent Technologies, Santa Clara, USA). LA L647R was used to ͸Ͷ͹ȀͶͲͳǡ͸Ͷ͹Ȁͷʹ͹͸Ͷ͹ȀͷͲ͸Ǥϐ
sequencing (BMR, Padua, Italy). Mutagenesis primers (Invitrogen) used are shown in  Suppl. Table S1 (for 
all online suppl. material, see www.karger.com/doi/10.1159/000477309).
Preparation of protein extracts and co-immunoprecipitation
Total lysates were prepared in AT lysis buffer (20mM Tris-HCl 7.0, 1% NP-40, 150mM NaCl, 10% 
glycerol, 10mM EDTA, 20mM NAF, 5mM Na
4
P
2
O
7
, 1mM Na
3
VO
4
, 1mM PMSF and protease inhibitors (Thermo-ϐǡǡȌͶιǤ
For nuclear extraction: transfected-HEK 293T were trypsinized and resuspended in hypotonic buffer 
(10mM Tris-HCl pH 7.8, 5mM MgCl
2
). Then, 0.3% Triton was added. Cells were then sheared through a 22-G 
needle. Nuclei were recovered by centrifugation, lysed in AT lysis buffer and cleared by centrifugation. The 
purity of nuclei was analyzed by immunoblot detection of E-tubulin.
For co-immunoprecipitation experiments, cells were lysed in CC buffer (50mM Tris-HCl 8.0, 150mM 
NaCl, 1% NP40, 0.1% SDS and protease inhibitors). Lysates (1-2mg) were incubated with 2Ɋg of antibody at ͶιǤȀ
ǦȋǦǡǡȌǤǡϐǤ
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Immunochemical analysis
50Pg of lysates were resolved on SDS-PAGE. Proteins were blotted onto nitrocellulose (BioRad). For the 
detection of human or mouse Ankdr2, the following antibodies were used: polyclonal anti Ankrd2, (PtgLab 
Chicago, USA) and monoclonal anti-Ankrd2, clone YAS11 (LS-Bio Seattle, USA). As stated by the companies, 
these two antibodies have been raised against epitopes shared by the S- and the M- Ankrd2 isoforms. Other 
antibodies were: anti -Akt SC-1619, -Akt SC-1618, -Lamin A/C SC-6215, -Lamin A SC-6214, -GFP, -PARP-1 
SC-7150, -Bcl-2 SC-7382, caspase-3 SC-7148, BAX sc-7480 (all Santa Cruz, USA). 
ϔϐ͹ǦͳͷǯǤ     Ͷι   ϐǦ   ȋǡ
Denmark, or Santa Cruz, USA). Coverslips were washed and mounted with an antifade/DAPI reagent ȋǦǡȌǤǦ͸ͲͲϐǡ
the NIS-Elements AR-software. 
Measurement of intracellular ROS level
HEK 293T were transfected according to the experimental conditions.   ϐ
interference, whenever required, a vector encoding Flag-tagged Ankrd2 was used to overexpress Ankrd2 
in these experiments. The day before the experiment, cells were splitted and 5x104 cells were seeded in 
triplicate in a 96-wells culture plate. The next day, cells were washed and incubated with 15ɊM DCFDA ȋϐǦǡ Ǧ Ȍ  ͵Ͳǯ  ͵͹ιǤ     
2
O
2
 or left Ǥ		ȋϐȌϐȋϐʹͲͲǦ͸ͳͳͲǡǡȌǤ
96-wells culture plate, differentiated for three weeks and then processed as already described.
All the images shown are representative of at least three independent experiments carried out under 
the same conditions. ϐ
Adobe-Photoshop CS 8.0 (Adobe-Systems). Densitometric and statistical analysis were performed by ImageJ 
and GraphPad Prism5 software.
Results
Ankrd2 interacts with lamin A and prelamin A, and is mislocated from the cytoplasm to the 
nucleus by farnesylated prelamin A 
Ankrd2 and LMNA products have several features in common: they are upregulated 
during muscle differentiation, have a nuclear localization (which is constitutive for lamin 
A/C and regulated for Ankrd2), and interact with chromatin and transcription factors, such 
as p53. Thus, we wondered whether these proteins might interact with each other. HEK 293T 
cells, which do not endogenously express Ankrd2, and have negligible amounts of endogenous 
lamin A or C [33], were co-transfected with vectors encoding GFP-Ankrd2 and Flag-tagged 
constructs encoding wild-type lamin A (LA WT) or some unprocessable intermediates 
of lamin A maturation, such as non-farnesylable (LA C661M), and carboxymethylated-
farnesylated prelamin A (LA L647R). A scheme of lamin A maturation steps and mutants 
used in this work is depicted in Fig. S1, see supplementary material.
Cell lysates of Flag-LA constructs transfected in HEK293T cells were immunoprecipitated 
and analyzed for Ankrd2. Results shown in Fig. 1A demonstrate that Ankrd2 is able to 
complex with all the forms of lamin A tested. However, more Ankrd2 was found in prelamin 
A immunoprecipitates, in particular in the LA L647R one. ϐʹ
by prelamin A accumulation, HEK 293T cells were transfected with GFP-Ankrd2 alone or 
in combination with Flag-LA constructs, and subjected to cellular fractionation. Results 
shown in Fig. 1B, revealed that the simultaneous co-expression with LA C661M and even 
more so with LA L647R increased Ankrd2 accumulation in the nuclear fraction, compared 
to what was observed when it was co-expressed with LA WT (respectively of ~45% and 
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Fig. 1. Lamin A and farnesylated prela-
min A interact with Ankrd2, but only 
farnesylated prelamin A shifts Ankrd2 
into the nucleus. HEK 293T cells were 
co-transfected with GFP-Ankrd2 and the 
indicated Flag (Fl)-lamin A constructs, 
encoding wild type mature lamin A (LA 
WT), non-farnesylable (LA C661M) and 
carboxymethylated-farnesylated prela-
min A (LA L647R), and with empty vec-
tor (EV) as control, After 24 hours, cells 
were processed for: A) Co-immunopre-
cipitation assay: lamin A and prelamin 
A forms were immunoprecipitated from 
total cell lysates (T.L.) by an anti-Flag an-
tibody. Pellets were resolved on a 10% 
SDS-PAGE and subjected to immunoblot 
analysis. Representative western blots 
are shown. Bars were obtained by nor-
malizing GFP-Ankrd2 to Flag densito-
metric values from six independent co-
immunoprecipitation assays. Plots are 
mean ± SD (n = 6). *p < 0.05 vs. Ankrd2 
amount co-immunoprecipitated with LA 
WT. Western blots directed against GFP-
Ankrd2 (MW: 67kDa), and densitometric 
analysis revealed that Ankrd2 preferen-
tially binds to farnesylated prelamin A. 
Note that the unprocessable prelamin A 
species, i.e. LA C661M and LA L647R are 
about 15 aa longer than LA WT, and thus run slower. B) Nuclear extraction: Nuclear extracts isolated from 
transfected cells were lysed, resolved on SDS–PAGE and immunoblotted with an anti–GFP antibody. As as-
sessed by corresponding total lysates, GFP-Ankrd2 was equally transfected in each sample. Purity of iso lated 
nuclei was checked by Etubulin. HDAC2 was used as an equal loading control of nuclear lysates. Of note, 
when expressed alone, in HEK 293T cells (which express negligible levels of lamin A/C) GFP-Ankrd2 is ac-ǤϐǤ
obtained by normalizing densitometric values of GFP-Ankrd2 in the nucleus to those in total lysates from 
the corresponding sample. Plots are mean ± SD (n = 5). *p < 0.05 vs. GFP-Ankrd2 amount obtained from 	ǦȂǤȌϐǣǦʹͻ͵ǡ
GFP-Ankrd2 (green) localization was evaluated in combination with the indicated Flag (Fl)-lamin A forms 
stained in red by an anti Cy3-conjugated secondary antibody against the anti-Flag. Nuclei were counter-
stained with DAPI (blue). Bar 10 ɊǤϐȋȌϐ
gain more insight into GFP-Ankrd2 nuclear localization. As previously reported, Fl-LA L647R accumulation 
leads to the formation of nuclear lamina thickening, and is predominantly localized in the nucleoplasm, as 
well as the nuclear rim. Fl-LA C661M unprocessable prelamin A predominantly accumulated at intranuclear 
aggregates while a minor percentage of cells, showed a nuclear lamina distribution. The overexpression of 
Fl-LA L647R mutant led to the accumulation of GFP-Ankrd2 in the nuclei of 60±5% of co-transfected cells. It 
has to be reported that in a small percentage (8±2%) of Fl-LA C661M co-transfected cells, GFP-Ankrd2 was 
interestingly localized at the nuclear rim. 
~54% more, Fig. 1B). Of note, in HEK 293T cells expressing GFP-Ankrd2 alone, the amount 
of nuclear Ankrd2 was similar to that observed with the prelamin A form, maybe because of 
the absence of a normal nuclear lamina typical of these cells [33]. Increasing the detergent 
concentration in the extraction buffer (up to 1% Triton X-100), did not affect LA L647R-
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induced Ankrd2 accumulation in the nuclear fraction, indicating that Ankrd2 was not bound 
to the outer nuclear membrane (not shown). Further fractionation revealed that Ankrd2 
was accumulated in the insoluble nuclear fraction (In), containing the nuclear matrix and 
chromatin, after LA L647R, but not WT, expression (see supplementary material, Fig. S2).ʹϐǦǤ ϐ  ǡ     ǡ ʹ  
cytoplasmic and weakly nuclear. However, co-expression with the LA L647R mutant led 
Ankrd2 to be recruited to the nucleus in 60±5% of the transfected cells. Limited localization 
changes compared to control (Ankrd2-LA WT co-expressing cells) were detectable by co-
expressing LA C661M (read legend of Fig. 1C). 
Ankrd2 interacts strongly with EDMD2 mutated forms of farnesylated prelamin A
EDMD2 is a genetic disorder due to mutations of the LMNA gene encoding lamin A, 
impairing the development and functions of striated muscles. To get more insight into the 
role of the interaction between Ankrd2 and mutated lamin A in the pathophysiology of this 
disease, some forms of EDMD2-mutated lamin A were produced from LA WT, and their ϐʹǤ ǡLMNA mutations considered were: ǤͳʹͲͳεȀǤͶͲͳȏ͵ͶȐǡǤͳͷͺͲ
εȀǤͷʹ͹ȏʹ͵Ȑϐǡ
that is c.1517A>C leading to the p.H506P mutation, responsible for an EDMD2 associated to 
cardiac conduction defects (Cenni et al. manuscript in preparation). 
HEK 293T were co-transfected with vectors encoding GFP-Ankrd2 and the various forms 
of EDMD2-mutated lamin A. After 24 hours, the Flag constructs were immunoprecipitated 
from total lysates and then analyzed for Ankrd2. Results demonstrated that compared to LA 
WT, the presence of the EDMD2 mutations positively modulated the binding between lamin 
A and Ankd2 (Fig. 2A and 2B). 
We next tested whether the introduction of the same mutations in the unprocessable 
prelamin A mutant could affect the interaction between Ankrd2 and prelamin A already 
reported (Fig. 1A). To this aim, the double mutants L647R/R401C, L647R/H506P and 
L647R/R527P (hereafter indicated as dm R401C, dm H506P and dm R527P), were 
created and co-expressed with GFP-Ankrd2. Overexpressing cells were lysed and prelamin 
A forms immunoprecipitated.Results demonstrated that double lamin A mutants co-
immunoprecipitated an amount of Ankrd2 higher than that observed with LA WT or single 
EDMD2-lamin A mutants (Fig. 2A and 2B), or with LA L647R (see supplementary material, 
Fig. S3).  
To evaluate whether lamin A mutants were also able to recruit Ankrd2 to the nucleus, ʹϐϐǤ
all the EDMD mutated-lamin A forms tested were able to induce a portion of total Ankrd2 to ϐȋ	ǤʹȌǤ
To verify that the interaction between Ankrd2 with wild-type and mutated lamin A 
forms also occurs in a muscle model, C2C12 mouse muscle cells were cultured on coverslips, 
transfected with vectors encoding the various forms of Flag-tagged lamin A forms and 
differentiated for two days. Cells were blocked and slides incubated with anti-Flag antibody 
to stain transfected cells, and with anti-Ankrd2 antibody to stain endogenous Ankrd2. As 
shown in Fig. 2D, in mock and LA WT-transfected cells, Ankrd2 stained both the cytoplasm and Ǥǡϐǡ
EDMD2-lamin A, Ankrd2 localization became more nuclear (Fig. 2D). 
In C2C12 myotubes, H2O2 increases the binding between endogenous Ankrd2 and lamin A
As previously reported, oxidative stress induces a portion of Ankrd2 to translocate from 
the cytoplasm to the nucleus, affecting the activity of its effectors [9]. In an attempt to evaluate 
whether oxidative stress could modulate the binding between Ankrd2 and lamin A during 
Ankrd2 nuclear crossing, C2C12 cultured myotubes were stressed by H
2
O
2
 stimulation (f.c. 
450 PM) up to 5 hours, lysed and endogenous lamin A/C immunoprecipitated from total 
lysates. Fig. 3A shows that H
2
O
2
 stimulation positively promoted the interaction between 
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Fig. 2. Ankrd2 tightly 
interacts with EDMD2-
mutated forms of la-
min A and prelamin A. 
A) Co-immunoprecipi-
tation analysis of HEK 
293T cells transfected 
with GFP-Ankrd2 and 
Flag-lamin A con-
structs encoding wild 
type lamin A (LA WT), 
EDMD2 forms of lamin 
A, that is LA R401C, LA 
H506P and LA R527P, 
and EDMD2-forms of 
prelamin A, that is dou-
ble mutants L647R/
R401C, L647R/H506P 
and L647R/R527P 
(dm R401C, dm H506P 
and dm R527P). Af-
ter 18-24 hours from 
transfection, cells were 
lysed and lamin A spe-
cies immunoprecipi-
tated from total lysates 
(T.L.) by anti–Flag an-
tibody. GFP-Ankrd2 
amount was then ϐ   	Ǧ
immunocomplexes. Representative western blots are shown. B) Bar graph of A obtained by normalizing 
GFP-Ankrd2 to Flag densitometric values from three independent immunoprecipitation assays. Plots are 
mean ± SD (n = 3). *p δͲǤͲͷǤʹ	ǦȂǤȌϐ-
rescence analysis: GFP-Ankrd2 localization was evaluated in cells overexpressing Flag (Fl-) tagged EDMD2 
mutant forms of lamin A (LA R401C, LA H506P and LA R527P ) and prelamin A (dm R401C, dm H506P and 
dm R527P). Mutated lamin A overexpressing cells were detected by anti-Flag staining (red), bar 10 Ɋm. Ǧϐ
	ǦʹǤ-
factual data due to accumulation of transfected proteins, the same experiments were performed with serial 
dilutions of expression vectors (range of transfecting DNA used was from 0.2 to 1.5 Pg/well for a 6-well ȌǤȌϐʹͳʹ	Ǧ
LA R401C, LA H506P and LA R527P and induced to differentiate in differentiation medium. After two days ǡϐǤ	ϐǣϐǡ-
dogenous Ankrd2 (green) and Flag tagged EDMD2-lamin A mutants (stained with anti-Flag/cy3-conjugated 
antibody from Sigma). Bar 10Pm. Similar results were obtained by serial dilution of transfected cDNA vec-ȋȌǤϐʹ
exogenous lamins. Representative blots from three independent experiments are shown.
Ankrd2 and lamin A/C. It should be noted that Ankrd2 did co-immunoprecipitate with ȀǡϐǤ
Interestingly, after three hours of treatment, the amount of Ankrd2 bound to lamin A/C 
started decreasing. ʹȀϐǤ
C2C12 myotubes were grown on coverslips and cultured and treated as before. At the end of 
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Fig. 3. H
2
O
2
 stimu-
lation positively 
modulates the 
binding between 
wild-type forms 
of mature lamin 
A and prelamin A 
but not that with 
o v e r e x p r e s s e d 
EDMD2 mutated 
forms of lamin A. 
To evaluate wheth-
er H
2
O
2
 modulates 
the binding of en-
dogenous Ankrd2 
and lamin A/C 
also in a muscle 
model: A) C2C12 
cells were seeded 
in p100 plates 
with coverlips in-
side, differentiated 
for 2 days and ex-
posed to 450 ɊM 
H
2
O
2
 for the indi-
cated times, or left 
untreated. At the 
end of every treat-
ment, cells were 
lysed and endog-
enous lamin A/C 
immunoprecipi-
tated by an anti-la-
min A/C antibody 
(SC-6215, directed 
against lamin A/C 
and prelamin A) 
from total lysates 
(T.L.). As a control, 
anti IgG sera was 
incubated with 
same amount of 
untreated total ly-
sate. H
2
O
2
 stimula-ϐǦͶ͹͵ȋǦǡȌǤ-
nocomplexes were immunoblotted with an anti Ankrd2 antibody (polyclonal). Representative western blots 
are shown. Bar graph was obtained by normalizing immunoprecipitated Ankrd2 to lamin A/C densitometric 
values from three independent experiments. Plots are mean ± SD (n = 3). *p ζͲǤͲͷǤʹ-
tained from untreated complexes. H
2
O
2
 stimulation promoted the interaction between Ankrd2 and lamin Ȁ̱ͳͷΨǤȌϐʹ
stress, coverslips from A) treated for 3 hours with H
2
O
2
ǡϐ-
cence analysis and incubated with antibodies directed against endogenous Ankrd2 (green) and endogenous 
lamin A/C (red). Partial nuclear co-localization of Ankrd2 and lamin A increases upon stimulation, as sug-
gested by the yellow signal. To check whether H
2
O
2
 affects the extent of the interaction between Ankrd2 
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ǡϐʹȀǤ	Ǥ͵
shows that in untreated controls (NT), Ankrd2 was mainly cytosolic and faintly nuclear in 
70% of the myotubes. In this context, it was also evident that the signals of Ankrd2 and lamin 
A/C merged at the nuclear rim (see the yellow staining at the nuclear rim Fig. 3B, NT). In 
the remaining percentage, consistent with the active role of Ankrd2 in coordinating muscle 
differentiation from the nuclei [4], Ankrd2 was also localized inside the nuclei (not shown).
Myotube exposure to oxidative stress induced a partial translocation of Ankrd2 
to the nucleus, clearly detectable after three (Fig. 3B, H
2
O
2
Ȍ ϐ ȋ Ȍ
stimulation. Under these conditions, the merged signal from Ankrd2 and lamin A/C staining 
at the nucleus became clearer (Fig. 3B, H
2
O
2
). ǡ Ǧ ȋ	Ǥ͵Ȍ ϐ ȋ	Ǥ͵Ȍ
results suggest that the increased binding between Ankrd2 and lamin A observed upon the 
application of oxidative stress, probably contributes to the increase in nuclear localization 
of Ankrd2.
We next tested if oxidative stress might modulate also the interaction between Ankrd2 
and the EDMD2 mutated forms of lamin A. HEK 293T were transfected with GFP-Ankrd2 in 
combination with Flag-tagged constructs encoding LA WT, LA L647R, and single or double 
EDMD2-lamin A mutants. Cells were subjected to stress by H
2
O
2
 stimulation for a short (30 
minutes) or a longer (3 hours) exposure, and Flag immunoprecipitated from total lysates. 
Results shown in Fig. 3C and 3D revealed that short exposure to H
2
O
2
 stimulation (30 min) 
upregulated Ankrd2 binding to LA WT or farnesylated prelamin A, whereas it reduced 
Ankrd2 binding to mutated forms of lamin A (Fig. 3C and 3D). Interestingly, longer H
2
O
2
 
exposure decreased Ankrd2 binding to all the WT and mutant lamin A forms considered, 
except for the double mutants dm R401C and dm R527P (Fig. 3C and 3D).
To get more insight into Ankrd2 subcellular distribution following H
2
O
2
 stimulation, 
HEK 293T cells were co-transfected with Ankrd2 and lamin A wild type (LA WT) or double 
mutants, and treated with H
2
O
2
 as before. Cells were collected after 30 minutes and 3 hours ǡʹϐǤ
Results shown in Fig. 3E demonstrated that in Ankrd2-LA WT co-transfected cells, the 
application of stress immediately induced Ankrd2 to shuttle to the nucleus. However, the 
presence of Ankrd2 in the nucleus was not enduring, as longer H
2
O
2
 exposure reduced its 
amount (Fig. 3E). This evidence suggests that upon the application of H
2
O
2
, Ankrd2 crosses 
and mutated forms of lamin A or prelamin A, HEK 293T cells were transfected with GFP-Ankrd2 and the 
indicated forms of Flag (Fl-) tagged lamin A (C) and prelamin A (D) constructs. After 48 hours, cells were 
stimulated with 450 µM H
2
O
2
 for the indicated times, and Flag-tagged proteins were immunoprecipitated 
by anti-Flag antibody. Immunocomplexes were resolved by a 8% SDS-PAGE and GFP-Ankrd2 amount was ϐǤ
2
O
2
ϐʹǦͳ͵ͻȋJH2AX, 
from Abcam). Representative blots are shown. Bar graphs were obtained by normalizing GFP-Ankrd2 to 
Flag densitometric values from three independent experiments. Plots are mean ± SD (n = 3). *p < 0.05 with 
black asterisks vs. GFP-Ankrd2 amount obtained from precipitates with the same lamin A construct un-
treated samples. *p < 0.05 with red asterisks vs. GFP-Ankrd2 amount obtained from precipitates with LA 
WT for C) and with LA L647R for D). E) To evaluate whether GFP-Ankrd2 accumulation into the nuclear frac-
tion following H
2
O
2
 stimulation might be affected by mutated lamin A overexpression, HEK 293T cells were 
transfected with GFP-Ankrd2 and the reported Flag tagged double mutants forms of lamin A (dm R401C, dm 
H506P and dm R527P) and with Fl-lamin A WT (WT) as the control. After 24 h of transfection, cells were 
subjected to nuclear extraction. Total lysates and nuclear extracts were resolved by 10% SDS-PAGE and 
blotted with the reported anti-Ankrd2 antibody. Lamin B1 was used as equal loading control of total and 
nuclear lysates. Purity of the nuclear fraction was validated by the absence of E-tubulin (not shown). Repre-
sentative blots are shown. Bars graphs were obtained from densitometric analysis of nuclear GFP-Ankrd2 of 
three independent experiments, values were normalized to nuclear lamin B1 and indicate means ± S.D (n= 
3). *p < 0.05 vs. GFP-Ankrd2 nuclear amount obtained from the same lamin A construct-transfected control 
(untreated) samples. *p < 0.05 with red asterisks vs. GFP-Ankrd2 nuclear amount obtained from LA WT 
transfected and untreated cells.
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the nuclear lamina, by interacting with lamin A, accumulating in the nucleus for a certain 
time frame and then cycling back into the cytoplasm shortly after. ϐʹǦ
A-EDMD2- lamin A-mutants. Under these experimental conditions in fact, the amount of 
nuclear Ankrd2 was clearly higher than that observed in control cells (Ankrd2-LA WT co-
transfected one) and what is more, persistent H
2
O
2
 stimulation did not reduce Ankrd2 amount ǡǡǲǳ
mutated lamin A (Fig. 3D). Of note, in LA dm R527P co-transfectants, upon three hours of 
treatment, the amount of nuclear Ankrd2 remarkably decreased (Fig. 3E). Albeit substantial, 
this reduction resulted in a nuclear retention of Ankrd2 that was higher than that observed ǡϐǤ
Ankrd2 localization in primary muscle cultures from EDMD2-affected human donors
With the purpose of investigating whether Ankrd2 subcellular localization is impaired 
also in myotubes from EDMD2-affected patients, human muscle cultures obtained from 
healthy donors and donors suffering from an EDMD2 form with severe conduction defects, 
were grown, differentiated and processed for an ex vivo analysis of Ankrd2 localization. 
Ankrd2 immunostaining revealed that Ankrd2 had a similar cytoplasmic localization both 
in healthy and in pathological samples. Analysis of Ankrd2 nuclear staining of both samples 
revealed that Ankrd2 partially co-localized with lamin A/C at the nuclear lamina. However, 
Fig. 4. Analysis of Ankrd2 subcellular lo-
calization and ROS release upon oxidative 
stress stimulation in human cultured EDMD2 
muscle cells. A) Primary human muscle cul-
tures from healthy (Control) and EDMD2 
donors (EDMD2 a and b) (LMNA mutation: 
c.1517A>C/p.H506P) were cultured and dif-
ferentiated on coverslips. After 3 weeks, cells ϐ
stained for Ankrd2 (green) and lamin A/C 
(red); chromatin was counterstained with 
DAPI. Bar 10 ɊǤ   ϐ -
clei (indicated by arrowheads) were magni-ϐʹǤ
co-localization signals between Ankrd2 and 
lamin A/C are evidenced by arrows. Repre-
sented EDMD2 myotubes highlight differenc-
es in nuclear morphology that can be found 
in the culture. In particular: a) shows little or 
no dysmorphic nuclei, while b) shows highly 
dysmorphic nuclei. B) Primary human mus-
cle cultures from the healthy and EDMD2 
donors of A) were cultured in triplicates in ͻ͸Ǧ     ǲǳǤ
When similar levels of differentiation were ȋϐη͵Ȍǡϐ-
cein-diacetate (DCF-DA), stimulated with 100 PM H
2
O
2
 and ROS levels immediately measured as described. 
In unstimulated conditions, healthy and EDMD2 myotubes released similar amount of ROS. However, fol-
lowing 90 minutes of H
2
O
2 
exposure, ROS released from EDMD2 myotubes was 30% greater than those from 
control samples. Graph represents the mean ±SD (n=3), *p < 0.05 vs. control muscle cells treated under the 
same conditions. C) To demonstrate the levels of Ankrd2 expression, at the end of the experiment control 
and EDMD2 cultures were lysed in 40Pl of SDS-buffer, loaded on a 12% SDS-PAGE, and immunoblotted with 
antibodies against Ankrd2. E-tubulin was used to demonstrate equal loading. 
Cell Physiol Biochem 2017;42:169-184
DOI: 10.1159/000477309
Published online: May 18, 2017 179
Angori et al.: Ankrd2 is a Novel Interactor of Lamin A and Prelamin A
Cellular Physiology 
and Biochemistry
© 2017 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
whereas in healthy conditions Ankrd2 was poorly localized at the nuclear rim of 70% of total 
nuclei (Fig. 4A, Control), in nuclei of pathological myotubes Ankrd2 antibody stained a higher ȋ̱ͻͲΨȌȋ	ǤͶǡʹǦȌǤϐ
with the results shown in Fig. 2, on the nuclear recruitment of Ankrd2 in HEK 293T and 
C2C12 muscle cells overexpressing EDMD2 mutated forms of lamin A or prelamin A. Finally, 
nuclear dysmorphism was clearly detectable in EDMD2 myotubes (about more than the half 
of the culture). In these conditions, although the loss of nuclear boundaries was evident (Fig. 
4A, EDMD2-b), the partial co-localization of Ankrd2 and lamin A/C in proximity of nuclear 
aberrant structures A/C was still clearly detectable (Fig. 4A, EDMD2-b).ǡ ϐ   ȏʹʹǡ ͵ͷǡ ͵͸Ȑǡ   ϐ  
patient responded to H
2
O
2
 stimulation by increasing the amount of ROS release of about 
30%, compared to the control (Fig. 4B). At the end of the assay, the analysis of the cell lysates 
revealed similar level of Ankrd2 expression (Fig. 4C). The results shown in Fig. 4A and 4B and 
the fact that Ankrd2 is a stress responsive protein led us to hypothesize that the localization 
of Ankrd2 in the nuclei of EDMD2 cells might be involved in their altered stress response.  
Concomitant expression of Ankrd2 and pathological lamin A forms affect ROS release and 
cell viability in response to stress stimulation 
In dystrophic muscle cells, the dysfunctional nuclear lamina caused by the accumulation 
of mutated lamin A, leads to an anomalous increase of the amount of cellular ROS, dramatically 
concurring with the impairment of the pathology [26]. Therefore, we wondered whether the 
forms examined in this work were able to increase the cellular susceptibility to stress. HEK 
293T overexpressing wild-type or EDMD2 lamin A forms were stimulated with H
2
O
2
, and the ϐ	ǦǤ
Results shown in Fig. 5A demonstrate that following H
2
O
2
 stimulation, LA dm 
R527P-overexpressing cells released an amount of ROS higher (~ 12%) than the LA WT  Ǥ  ϐ    ʹǦ ǡ
although the LA double mutant overexpression was always much more effective than the 
single counterparts (not shown). 
With the aim of demonstrating whether the observed ROS increase might be affected 
by Ankrd2 accumulation in the nucleus, HEK 293T cells were co-transfected with vectors 
encoding Ankrd2 and lamin A WT or mutated forms, stressed and assayed for ROS release 
as before. Surprisingly, co-expression of Ankrd2 and LA dm R527P increased the amount of 
ROS released by more than 20% compared to cells expressing LA dm R527P alone (Fig. 5A), 
more than 35% compared to cells expressing LA WT alone, and more than 30% compared to 
cells expressing Ankrd2 and LA WT. The analysis of the corresponding lysates revealed that 
all the samples were properly transfected (Fig. 5B). 
To investigate whether the simultaneous expression of Ankrd2 and LA dm R527P was 
also able to affect cell viability in response to stress, HEK 293T cells were transfected as 
before and subjected to stress at various time points. At the end of every treatment, viable 
cells were counted by Trypan blue exclusion. Simultaneous expression of Ankrd2 and LA 
dm R527P halved cellular viability ~3 hours before that of cells expressing LA dm R527P 
alone or Ankrd2 in combination with LA WT (Fig. 5C). Immunochemical analysis of the same 
samples indicated that cell death had apoptotic features (Fig. 5D). 
Taken together, these data demonstrate that the dysfunctional nuclear lamina, together 
with the nuclear recruitment of Ankrd2, induced by mutated lamina itself, synergistically act 
to increase cellular susceptibility to stress. 
Discussion
The results presented in this study point to Ankrd2 as a new interactor of lamin A 
and its precursor prelamin A. In particular, our results reveal that prelamin A is able to 
complex with higher amounts of Ankrd2 compared to mature lamin A, suggesting that in 
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Fig. 5. Analysis of the response to 
oxidative stress in cells co-expressing 
Ankrd2 and EDMD2-mutant form of 
prelamin A. A) HEK 293T cells were 
transfected with constructs encod-
ing Flag (Fl-) tagged lamin A WT (LA 
WT) or LA dm R527P, chosen as an 
EDMD2-mutated prelamin A represen-
tative mutant, plus, where indicated, 
Flag tagged Ankrd2, and loaded with 
DCFDA. As control of toxicity, untrans-
fected cells (Not Transfected) were 
subjected to the same test. Cells were 
next exposed to stress by H
2
O
2
 stimu-
lation (f.c. 450 PM) and the amount of 
ROS released immediately evaluated 
as the amount of oxidized DCF (DCF-
HDA). The graph reports ROS values 
in untreated conditions (-) and after 
25 minutes from H
2
O
2
 application from 
triplicate readings. Data are the mean 
from three independent experiments 
(one of which is shown here) ± SD. Sta- ϐ  
respect to the control (LA WT- trans-
fected cells) value were determined by ǯǦȋp < 0.05). Expres-
sion of Fl-LA dm R527P increased the 
amount of ROS by 12% compared to 
the control (cells expressing Fl-LA WT 
alone), whereas co-expression of Fl-
Ankrd2 and Fl-LA dm R527P increased 
the amount of ROS by more than 35% 
compared to the control, and more 
than 30% compared to Fl-LA WT and 
Fl-Ankrd2. B) At the end of the experi-
ment, samples were lysed and subject-
ed to Western blot analysis to detect 
	Ǧʹ	ǦǤ ϐǤȌʹͻ͵ 
p100 were transfected as before. The next day, cells were trypsinized and plated at a density of 0.5x106/well 
onto a 6-well plate. After 24 hours cells were subjected to oxidative stress by 450 PM H
2
O
2
 stimulation. After 7 
and 24 hours, cell viability was assessed by the Trypan blue assay. Dotted lines indicate the time at which cells 
halve their number. Graphs are presented with the percent cell viability ±SD for the respective independent 
experiments (n= 3). D) To verify apoptotic cell death, HEK 293T cells of C) were collected at the end of each 
treatments and lysed. Total lysates were immunoblotted with antibodies directed against PARP-1, caspase-3 
and BAX.  Equal levels of transfection of GFP-Ankrd2 and Flag lamins are shownǤȾǦ-ϐǤȌǣ
donors, in untreated cells (Untr.), the nuclear lamina is principally made of mature lamin A. In these condi-
tions, Ankrd2 poorly binds to lamin A, and is weakly found in the nuclei of cells. Ankrd2 shuttling to the 
nucleus, which is observed upon mechanical, or oxidative (H
2
O
2
) stress application, or muscle differentiation, 
probably occurs also as a consequence of prelamin A accumulation at the nuclear lamina (observed under the 
same conditions by other Authors, see text), which in turn interacts with Ankrd2 resulting in Ankrd2 nuclear 
recruitment. In pathological conditions (EDMD2), nuclear lamina mainly consist of mutated prelamin A and 
lamin A, which are able to recruit Ankrd2 even in the absence of stimulation.
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in vivo conditions, this intermediate might form a stronger interaction with Ankrd2. We are 
currently involved in interaction studies to assess the nature of Ankrd2 binding to lamin A or 
farnesylated prelamin A, whether it is direct or mediated by other molecules. ʹǲǳ
nucleus of the cells. In an attempt to assess whether Ankrd2 subcellular localization might be 
affected by its interaction with prelamin A, we also demonstrated that when overexpressed 
with this precursor, and not with mature lamin A, Ankrd2 partially redistributes to the 
nucleus (Fig. 1 and S2, see supplementary material). Interestingly, we proved that the 
interaction between Ankrd2 and farnesylated prelamin A, or mature lamin A, is not static 
but positively modulated by oxidative stress application which, as already reported, induces 
Ankrd2 translocation into the nucleus. In particular, in the last years, farnesylated prelamin 
A has been indicated as more than a simple precursor fastly processed to give lamin A. 
Recent studies have in fact demonstrated the centrality of the role played by prelamin A 
in some cellular events, such as myogenesis, that requires the accumulation of prelamin 
A to coordinate proper nuclear positioning in muscle cells [28, 30], or the oxidative stress 
response, in which elevated levels of prelamin A by inducing DNA damage, lead to premature 
cellular senescence [37, 38]. Our evidence thus suggest the existence of a multimeric complex 
consisting of Ankrd2, mature lamin A and prelamin A, the composition of which is ruled by 
cellular conditions. In non-pathological conditions, at the steady state, this complex features 
a huge amount of mature lamin A which weakly binds to Ankrd2, thus causing Ankrd2 to 
be poorly accumulated at the nuclear level. Following the application of stress, or myogenic 
stimuli arrival, the multimeric complex changes its composition, accumulating prelamin A 
that in turn acts by pulling in Ankrd2. At this point, after being brought closer to the nucleus, 
through mechanisms still to be elucidated, Ankrd2 translocates into the nucleus. 
In an attempt to assess Ankrd2 involvement in the pathophysiology of EDMD2, a muscle 
disorder associated with mutations in the LMNA gene, Ankrd2 was assayed for its ability 
to bind some mutated forms of lamin A causative of this pathology. Our results prove that 
compared to wild type counterparts, EDMD2-mutated forms of lamin A or prelamin A form a ʹǤ	ǡǦǡǲǳ
interactions are not increased by stress stimulation (Fig. 2A and 2B). Nevertheless, in vivo 
analysis revealed that all the EDMD2-forms of lamin A tested are also able to affect the regular 
localization of Ankrd2, inducing a partial recruitment of Ankrd2 to the nucleus (Fig. 2C, 2D 
and 3E). It is interesting to note, that the mutant forms of lamins appeared to cause two 
distinct nuclear phenotypes for Ankrd2, that is a diffuse nuclear staining and punctate foci. 
Although at the moment we are unable to assess what are the downstream consequences of 
these Ankrd2 nuclear patterns, we exclude that they might be related to the relative levels of 
exogenous proteins, but rather to the severity of the lamin A mutation.
According to the latest evidence, it was reasonable to speculate that also in pathological 
muscle cells, Ankrd2 is sequestered and mislocated in the nucleus by mutated lamin A. ϐǡ
an EDMD2 affected donor, and opposite to unaffected myotubes, Ankrd2 is typically found in 
a high percentage of nuclei (Fig. 4A). 
Going back to our multimeric complex model, in pathological conditions, the complex 
Ankrd2-lamin A-prelamin A is enriched in mutated lamin A or prelamin A which, as ǡϐ ʹǡ ʹ 
constitutively localized at the nuclear level, also in the absence of stimuli (a schematic 
cartoon is depicted in Fig. 5E). 
Very recently, it has been reported that, besides the S-Ankrd2 isoform studied in this 
paper, nuclei of primary differentiated myotubes also feature a longer Ankrd2 isoform, 
that is M-Ankrd2, which is identical to the S- one except for a unique region of 27 amino Ǧȏ͵ȐǤϐǡʹ
affected myotubes might be due to the stronger interaction formed between S-Ankrd2 and 
the EDMD2-lamin A. Future experiments are planned to investigate whether and how lamin 
A also interacts with the M-Ankrd2 isoform. 
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In dystrophic muscle cells, the accumulation of mutated lamin A leads to an anomalous 
increase of the amount of cellular ROS in response to mechanical [36] or oxidative stress 
[27, 39-41], concurring to the impairment of the pathology [26]. This evidence has also been ϐ  ȋǡ	ǤͶȌǤ  investigating whether 
the nuclear recruitment of Ankrd2 concomitant with EDMD2-lamin A overexpression 
might affect the cellular response to oxidative stress, our results prove that the combined 
expression of Ankrd2 and EDMD2 - lamin A is toxic, as it resulted in an increase of cellular 
sensibility to stress (Fig. 5A) associated to a premature apoptotic cell death (Fig. 5C and 5D). 
Evidence is necessary to verify the exact connection between Ankrd2 nuclear accumulation 
and increased ROS release in response to stress. Supported by our data, we therefore suggest 
that the nuclear accumulation of Ankrd2 observed in human EDMD2 muscle cells might 
contribute to generate the abnormal response to oxidative stress observed in Fig. 4B. ǡϐʹǦȋȌǦϐǡ
Ankrd2 resulting in a general disorganization within the sarcomere [42]. Similarly, recent ϐ   ʹ         ϐȏͶ͵ȐǤ
In this context, it should be interesting to evaluate if and how the nuclear accumulation of ʹ        ʹ ϐǣ  
Ankrd2 molecules from the sarcomeric fraction, or maybe by affecting the expression of 
genes involved in the formation of functional sarcomeres, or both. To us, this is an interesting 
issue that undoubtedly warrants further investigations. 
All in all, by suggesting a molecular mechanism ruling the anomalous nuclear 
accumulation of Ankrd2 during the expression of some EDMD2-associated forms of lamin ǡϐϐʹ
functions of lamin A, laying the foundations for future investigations related to the 
pathophysiology of EDMD2. 
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